Last 12 months
Inside the activity.
0 purchase rows · 3 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 2 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 1 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 30, 2026 Filed Jul 1, 2026 20:10 UTC |
Shefferman JesseDirector · CEO and President
|
GiftCommon Stock | 5,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001213900-26-074238 · marketforms-73501.xml · nonDerivative · entry 6 Shefferman Jesse · CIK 0001799167 · Director · CEO and President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 691,832 Read SEC document |
| June 30, 2026 Filed Jul 1, 2026 20:10 UTC |
Shefferman JesseDirector · CEO and President
|
GiftCommon Stock | 4,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001213900-26-074238 · marketforms-73501.xml · nonDerivative · entry 5 Shefferman Jesse · CIK 0001799167 · Director · CEO and President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 696,832 Read SEC document |
| June 30, 2026 Filed Jul 1, 2026 20:10 UTC |
Shefferman JesseDirector · CEO and President
|
GiftCommon Stock | 7,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001213900-26-074238 · marketforms-73501.xml · nonDerivative · entry 4 Shefferman Jesse · CIK 0001799167 · Director · CEO and President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 700,832 Read SEC document |
| June 30, 2026 Filed Jul 1, 2026 20:10 UTC |
Shefferman JesseDirector · CEO and President
|
GiftCommon Stock | 14,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001213900-26-074238 · marketforms-73501.xml · nonDerivative · entry 3 Shefferman Jesse · CIK 0001799167 · Director · CEO and President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 707,832 Read SEC document |
| June 29, 2026 Filed Jul 1, 2026 20:10 UTC |
Shefferman JesseDirector · CEO and President
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 215,687 | $0.00 Strike: $1.91 | $0.00 |
DisclosureSEC source: 0001213900-26-074238 · marketforms-73501.xml · derivative · entry 8 Shefferman Jesse · CIK 0001799167 · Director · CEO and President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 141,313 Underlying: Common Stock · 215,687 shares Expires 2034-01-18 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: 25% of the shares underlying the option vested on January 19, 2025 and the remaining shares have vested or will vest in equal monthly installments thereafter over the following 36 months, subject to the Reporting Person's continuous service with the Issuer as of each such date. Read SEC document |
| June 29, 2026 Filed Jul 1, 2026 20:10 UTC |
Shefferman JesseDirector · CEO and President
|
SaleCommon Stock | 215,687 | $4.09 | $882,159.83 |
DisclosureSEC source: 0001213900-26-074238 · marketforms-73501.xml · nonDerivative · entry 2 Shefferman Jesse · CIK 0001799167 · Director · CEO and President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 721,832 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.03 to $4.14, inclusive. The reporting person undertakes to provide to TARA, any security holder of TARA, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Read SEC document |
| June 29, 2026 Filed Jul 1, 2026 20:10 UTC |
Shefferman JesseDirector · CEO and President
|
Exercise / conversionCommon Stock | 215,687 | $1.91 | $411,962.17 |
DisclosureSEC source: 0001213900-26-074238 · marketforms-73501.xml · nonDerivative · entry 1 Shefferman Jesse · CIK 0001799167 · Director · CEO and President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 937,519 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 15, 2026 Filed Jun 16, 2026 20:05 UTC |
Solomon Michael EdwardDirector
|
GrantStock Option (Right to Buy) · Derivative | 31,000 | $0.00 Strike: $3.94 | $0.00 |
DisclosureSEC source: 0001213900-26-069249 · marketforms-73186.xml · derivative · entry 1 Solomon Michael Edward · CIK 0001799320 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 31,000 Underlying: Common Stock · 31,000 shares Expires 2036-06-14 F1 · derivative.exercise_date: 1. The shares subject to the Annual Grant will vest in full upon the first anniversary of the date of grant, subject to the Eligible Director's continuous service as a member of the Board through such vesting date and will vest in full upon a Change of Control. Read SEC document |
| June 15, 2026 Filed Jun 16, 2026 20:05 UTC |
Huang JaneDirector
|
GrantStock Option (Right to Buy) · Derivative | 31,000 | $0.00 Strike: $3.94 | $0.00 |
DisclosureSEC source: 0001213900-26-069246 · marketforms-73183.xml · derivative · entry 1 Huang Jane · CIK 0001683913 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 31,000 Underlying: Common Stock · 31,000 shares Expires 2036-06-14 F1 · derivative.exercise_date: 1. The shares subject to the Annual Grant will vest in full upon the first anniversary of the date of grant, subject to the Eligible Director's continuous service as a member of the Board through such vesting date and will vest in full upon a Change of Control. Read SEC document |
| June 15, 2026 Filed Jun 16, 2026 20:05 UTC |
Levy Richard SDirector
|
GrantStock Option (Right to Buy) · Derivative | 31,000 | $0.00 Strike: $3.94 | $0.00 |
DisclosureSEC source: 0001213900-26-069250 · marketforms-73187.xml · derivative · entry 1 Levy Richard S · CIK 0001454983 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 31,000 Underlying: Common Stock · 31,000 shares Expires 2036-06-14 F1 · derivative.exercise_date: 1. The shares subject to the Annual Grant will vest in full upon the first anniversary of the date of grant, subject to the Eligible Director's continuous service as a member of the Board through such vesting date and will vest in full upon a Change of Control. Read SEC document |
| June 15, 2026 Filed Jun 16, 2026 20:05 UTC |
GARCEAU ROGERDirector
|
GrantStock Option (Right to Buy) · Derivative | 31,000 | $0.00 Strike: $3.94 | $0.00 |
DisclosureSEC source: 0001213900-26-069245 · marketforms-73182.xml · derivative · entry 1 GARCEAU ROGER · CIK 0001451767 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 31,000 Underlying: Common Stock · 31,000 shares Expires 2036-06-14 F1 · derivative.exercise_date: 1. The shares subject to the Annual Grant will vest in full upon the first anniversary of the date of grant, subject to the Eligible Director's continuous service as a member of the Board through such vesting date and will vest in full upon a Change of Control. Read SEC document |
| June 15, 2026 Filed Jun 16, 2026 20:05 UTC |
SARGEN GREGORYDirector
|
GrantStock Option (Right to Buy) · Derivative | 31,000 | $0.00 Strike: $3.94 | $0.00 |
DisclosureSEC source: 0001213900-26-069247 · marketforms-73184.xml · derivative · entry 1 SARGEN GREGORY · CIK 0001227835 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 31,000 Underlying: Common Stock · 31,000 shares Expires 2036-06-14 F1 · derivative.exercise_date: 1. The shares subject to the Annual Grant will vest in full upon the first anniversary of the date of grant, subject to the Eligible Director's continuous service as a member of the Board through such vesting date and will vest in full upon a Change of Control. Read SEC document |
| June 15, 2026 Filed Jun 16, 2026 20:05 UTC |
BESHAR LUKE MDirector
|
GrantStock Option (Right to Buy) · Derivative | 31,000 | $0.00 Strike: $3.94 | $0.00 |
DisclosureSEC source: 0001213900-26-069243 · marketforms-73180.xml · derivative · entry 1 BESHAR LUKE M · CIK 0001192128 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 31,000 Underlying: Common Stock · 31,000 shares Expires 2036-06-14 F1 · derivative.exercise_date: 1. The shares subject to the Annual Grant will vest in full upon the first anniversary of the date of grant, subject to the Eligible Director's continuous service as a member of the Board through such vesting date and will vest in full upon a Change of Control. Read SEC document |
| June 15, 2026 Filed Jun 16, 2026 20:05 UTC |
Smith CynthiaDirector
|
GrantStock Option (Right to Buy) · Derivative | 31,000 | $0.00 Strike: $3.94 | $0.00 |
DisclosureSEC source: 0001213900-26-069248 · marketforms-73185.xml · derivative · entry 1 Smith Cynthia · CIK 0001609480 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 31,000 Underlying: Common Stock · 31,000 shares Expires 2036-06-14 F1 · derivative.exercise_date: 1. The shares subject to the Annual Grant will vest in full upon the first anniversary of the date of grant, subject to the Eligible Director's continuous service as a member of the Board through such vesting date and will vest in full upon a Change of Control. Read SEC document |
| June 15, 2026 Filed Jun 16, 2026 20:05 UTC |
Flannelly Barry PDirector
|
GrantStock Option (Right to Buy) · Derivative | 31,000 | $0.00 Strike: $3.94 | $0.00 |
DisclosureSEC source: 0001213900-26-069244 · marketforms-73181.xml · derivative · entry 1 Flannelly Barry P · CIK 0001615842 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 31,000 Underlying: Common Stock · 31,000 shares Expires 2036-06-14 F1 · derivative.exercise_date: 1. The shares subject to the Annual Grant will vest in full upon the first anniversary of the date of grant, subject to the Eligible Director's continuous service as a member of the Board through such vesting date and will vest in full upon a Change of Control. Read SEC document |
| June 02, 2026 Filed Jun 3, 2026 20:55 UTC |
CONKLING WILLIAMChief Commercial Officer
|
Tax withholdingCommon Stock | 6,008 | $4.34 | $26,074.72 |
DisclosureSEC source: 0001213900-26-064792 · marketforms-73188.xml · nonDerivative · entry 1 CONKLING WILLIAM · CIK 0001852018 · Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 69,992 F1 · shares: 1. Represents shares withheld by the Issuer to satisfy income tax obligations associated with the vesting of Restricted Stock Unit Awards granted to the Reporting Person on June 2, 2025. Read SEC document |
| April 08, 2026 Filed Apr 9, 2026 21:25 UTC |
Zummo JacquelineChief R&D Officer
|
SaleCommon Stock | 1,134 | $5.40 | $6,123.60 |
DisclosureSEC source: 0001213900-26-042079 · marketforms-72911.xml · nonDerivative · entry 1 Zummo Jacqueline · CIK 0001798929 · Chief R&D Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 94,827 F1 · shares: The sale reported on this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan established by the reporting person on December 31, 2025. Read SEC document |
| April 01, 2026 Filed Apr 2, 2026 20:05 UTC |
Zummo JacquelineChief R&D Officer
|
SaleCommon Stock | 22,598 | $5.26 | $118,865.48 |
DisclosureSEC source: 0001213900-26-039328 · marketforms-72854.xml · nonDerivative · entry 1 Zummo Jacqueline · CIK 0001798929 · Chief R&D Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 95,961 F1 · shares: The sale reported on this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan established by the reporting person on December 31, 2025. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.25 to $5.31, inclusive. The reporting person undertakes to provide to TARA, any security holder of TARA, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Read SEC document |
| January 26, 2026 Filed Jan 27, 2026 21:10 UTC |
Zummo JacquelineChf Scientific Operations Off
|
Tax withholdingCommon Stock | 3,724 | $6.67 | $24,839.08 |
DisclosureSEC source: 0001213900-26-008223 · marketforms-71933.xml · nonDerivative · entry 1 Zummo Jacqueline · CIK 0001798929 · Chf Scientific Operations Off 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 118,559 F1 · shares: Represents shares withheld by the Issuer to satisfy income tax obligations associated with the vesting of a Restricted Stock Unit Award granted to the Reporting Person on January 24, 2025. Read SEC document |
| January 26, 2026 Filed Jan 27, 2026 21:10 UTC |
Fabbio PatrickChief Financial Officer
|
Tax withholdingCommon Stock | 3,261 | $6.67 | $21,750.87 |
DisclosureSEC source: 0001213900-26-008221 · marketforms-71931.xml · nonDerivative · entry 1 Fabbio Patrick · CIK 0001658859 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 64,115 F1 · shares: Represents shares withheld by the Issuer to satisfy income tax obligations associated with the vesting of a Restricted Stock Unit Award granted to the Reporting Person on January 24, 2025. Read SEC document |
| January 26, 2026 Filed Jan 27, 2026 21:10 UTC |
Fry HannahVP, Controller
|
Tax withholdingCommon Stock | 1,457 | $6.67 | $9,718.19 |
DisclosureSEC source: 0001213900-26-008222 · marketforms-71932.xml · nonDerivative · entry 1 Fry Hannah · CIK 0001938146 · VP, Controller 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 42,723 F1 · shares: Represents shares withheld by the Issuer to satisfy income tax obligations associated with the vesting of a Restricted Stock Unit Award granted to the Reporting Person on January 24, 2025. Read SEC document |
| January 26, 2026 Filed Jan 27, 2026 21:10 UTC |
Shefferman JesseDirector · CEO and President
|
Tax withholdingCommon Stock | 8,732 | $6.67 | $58,242.44 |
DisclosureSEC source: 0001213900-26-008224 · marketforms-71934.xml · nonDerivative · entry 1 Shefferman Jesse · CIK 0001799167 · Director · CEO and President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,021,832 F1 · shares: Represents shares withheld by the Issuer to satisfy income tax obligations associated with the vesting of a Restricted Stock Unit Award granted to the Reporting Person on January 24, 2025. Read SEC document |
| January 20, 2026 Filed Jan 22, 2026 21:30 UTC |
Zummo JacquelineChf Scientific Operations Off
|
Tax withholdingCommon Stock | 6,578 | $5.60 | $36,836.80 |
DisclosureSEC source: 0001213900-26-006708 · marketforms-71770.xml · nonDerivative · entry 1 Zummo Jacqueline · CIK 0001798929 · Chf Scientific Operations Off 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 122,283 F1 · shares: Represents shares withheld by the Issuer to satisfy income tax obligations associated with the vesting of Restricted Stock Unit Awards granted to the Reporting Person on January 19, 2023 and January 19, 2024. Read SEC document |
| January 20, 2026 Filed Jan 22, 2026 21:30 UTC |
Fabbio PatrickChief Financial Officer
|
Tax withholdingCommon Stock | 3,063 | $5.60 | $17,152.80 |
DisclosureSEC source: 0001213900-26-006709 · marketforms-71771.xml · nonDerivative · entry 1 Fabbio Patrick · CIK 0001658859 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 67,376 F1 · shares: Represents shares withheld by the Issuer to satisfy income tax obligations associated with the vesting of a Restricted Stock Unit Award granted to the Reporting Person on January 19, 2024. Read SEC document |
| January 20, 2026 Filed Jan 22, 2026 21:30 UTC |
Fry HannahVP, Controller
|
Tax withholdingCommon Stock | 2,132 | $5.60 | $11,939.20 |
DisclosureSEC source: 0001213900-26-006707 · marketforms-71769.xml · nonDerivative · entry 1 Fry Hannah · CIK 0001938146 · VP, Controller 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 44,180 F1 · shares: Represents shares withheld by the Issuer to satisfy income tax obligations associated with the vesting of Restricted Stock Unit Awards granted to the Reporting Person on January 19, 2023 and January 19, 2024. Read SEC document |
| January 20, 2026 Filed Jan 22, 2026 21:30 UTC |
Shefferman JesseDirector · CEO and President
|
Tax withholdingCommon Stock | 16,322 | $5.60 | $91,403.20 |
DisclosureSEC source: 0001213900-26-006711 · marketforms-71772.xml · nonDerivative · entry 1 Shefferman Jesse · CIK 0001799167 · Director · CEO and President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,030,564 F1 · shares: Represents shares withheld by the Issuer to satisfy income tax obligations associated with the vesting of Restricted Stock Unit Awards granted to the Reporting Person on January 19, 2023 and January 19, 2024. Read SEC document |
| January 16, 2026 Filed Jan 21, 2026 21:37 UTC |
CONKLING WILLIAMChief Commercial Officer
|
GrantStock Option (Right to Buy) · Derivative | 158,000 | $0.00 Strike: $5.01 | $0.00 |
DisclosureSEC source: 0001213900-26-006231 · marketforms-71898.xml · derivative · entry 2 CONKLING WILLIAM · CIK 0001852018 · Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 158,000 Underlying: Common Stock · 158,000 shares Expires 2036-01-15 F2 · derivative.exercise_date: 25% of the shares vest on the one year anniversary of January 16, 2026 and 1/48th of the shares vest monthly thereafter over the next three years, subject to the Reporting Person's continuous service with the Issuer as of each such date. Read SEC document |
| January 16, 2026 Filed Jan 21, 2026 21:37 UTC |
CONKLING WILLIAMChief Commercial Officer
|
GrantCommon Stock | 26,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001213900-26-006231 · marketforms-71898.xml · nonDerivative · entry 1 CONKLING WILLIAM · CIK 0001852018 · Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 76,000 F1 · shares: The shares being reported are being issued pursuant to restricted stock unit awards (RSUs), each of which represents a contingent right to receive one share of Issuer's common stock. The RSUs vest in equal one third installments on the first, second and third anniversaries of January 16, 2026, subject to the Reporting Person's continuous service with the Issuer as of each such date. Read SEC document |
| January 16, 2026 Filed Jan 21, 2026 21:36 UTC |
Zummo JacquelineChf Scientific Operations Off
|
GrantStock Option (Right to Buy) · Derivative | 180,000 | $0.00 Strike: $5.01 | $0.00 |
DisclosureSEC source: 0001213900-26-006225 · marketforms-71895.xml · derivative · entry 2 Zummo Jacqueline · CIK 0001798929 · Chf Scientific Operations Off 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 180,000 Underlying: Common Stock · 180,000 shares Expires 2036-01-15 F2 · derivative.exercise_date: 25% of the shares vest on the one year anniversary of January 16, 2026 and 1/48th of the shares vest monthly thereafter over the next three years, subject to the Reporting Person's continuous service with the Issuer as of each such date. Read SEC document |
| January 16, 2026 Filed Jan 21, 2026 21:36 UTC |
Zummo JacquelineChf Scientific Operations Off
|
GrantCommon Stock | 30,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001213900-26-006225 · marketforms-71895.xml · nonDerivative · entry 1 Zummo Jacqueline · CIK 0001798929 · Chf Scientific Operations Off 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 128,861 F1 · shares: The shares being reported are being issued pursuant to restricted stock unit awards (RSUs), each of which represents a contingent right to receive one share of Issuer's common stock. The RSUs vest in equal one third installments on the first, second and third anniversaries of January 16, 2026, subject to the Reporting Person's continuous service with the Issuer as of each such date. Read SEC document |
| January 16, 2026 Filed Jan 21, 2026 21:37 UTC |
Fabbio PatrickChief Financial Officer
|
GrantStock Option (Right to Buy) · Derivative | 175,000 | $0.00 Strike: $5.01 | $0.00 |
DisclosureSEC source: 0001213900-26-006230 · marketforms-71896.xml · derivative · entry 2 Fabbio Patrick · CIK 0001658859 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 175,000 Underlying: Common Stock · 175,000 shares Expires 2036-01-15 F2 · derivative.exercise_date: 25% of the shares vest on the one year anniversary of January 16, 2026 and 1/48th of the shares vest monthly thereafter over the next three years, subject to the Reporting Person's continuous service with the Issuer as of each such date. Read SEC document |
| January 16, 2026 Filed Jan 21, 2026 21:37 UTC |
Fabbio PatrickChief Financial Officer
|
GrantCommon Stock | 28,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001213900-26-006230 · marketforms-71896.xml · nonDerivative · entry 1 Fabbio Patrick · CIK 0001658859 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 70,439 F1 · shares: The shares being reported are being issued pursuant to restricted stock unit awards (RSUs), each of which represents a contingent right to receive one share of Issuer's common stock. The RSUs vest in equal one third installments on the first, second and third anniversaries of January 16, 2026, subject to the Reporting Person's continuous service with the Issuer as of each such date. Read SEC document |
| January 16, 2026 Filed Jan 21, 2026 21:36 UTC |
Fry HannahVP, Controller
|
GrantStock Option (Right to Buy) · Derivative | 55,000 | $0.00 Strike: $5.01 | $0.00 |
DisclosureSEC source: 0001213900-26-006229 · marketforms-71897.xml · derivative · entry 2 Fry Hannah · CIK 0001938146 · VP, Controller 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 55,000 Underlying: Common Stock · 55,000 shares Expires 2036-01-15 F2 · derivative.exercise_date: 25% of the shares vest on the one year anniversary of January 16, 2026 and 1/48th of the shares vest monthly thereafter over the next three years, subject to the Reporting Person's continuous service with the Issuer as of each such date. Read SEC document |
| January 16, 2026 Filed Jan 21, 2026 21:36 UTC |
Fry HannahVP, Controller
|
GrantCommon Stock | 9,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001213900-26-006229 · marketforms-71897.xml · nonDerivative · entry 1 Fry Hannah · CIK 0001938146 · VP, Controller 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 46,312 F1 · shares: The shares being reported are being issued pursuant to restricted stock unit awards (RSUs), each of which represents a contingent right to receive one share of Issuer's common stock. The RSUs vest in equal one third installments on the first, second and third anniversaries of January 16, 2026, subject to the Reporting Person's continuous service with the Issuer as of each such date. Read SEC document |
| January 16, 2026 Filed Jan 21, 2026 21:36 UTC |
Nicacio Leonardo VianaChief Medical Officer
|
GrantStock Option (Right to Buy) · Derivative | 158,000 | $0.00 Strike: $5.01 | $0.00 |
DisclosureSEC source: 0001213900-26-006228 · marketforms-71899.xml · derivative · entry 2 Nicacio Leonardo Viana · CIK 0002064901 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 158,000 Underlying: Common Stock · 158,000 shares Expires 2036-01-15 F2 · derivative.exercise_date: 25% of the shares vest on the one year anniversary of January 16, 2026 and 1/48th of the shares vest monthly thereafter over the next three years, subject to the Reporting Person's continuous service with the Issuer as of each such date. Read SEC document |
| January 16, 2026 Filed Jan 21, 2026 21:36 UTC |
Nicacio Leonardo VianaChief Medical Officer
|
GrantCommon Stock | 26,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001213900-26-006228 · marketforms-71899.xml · nonDerivative · entry 1 Nicacio Leonardo Viana · CIK 0002064901 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 78,181 F1 · shares: The shares being reported are being issued pursuant to restricted stock unit awards (RSUs), each of which represents a contingent right to receive one share of Issuer's common stock. The RSUs vest in equal one third installments on the first, second and third anniversaries of January 16, 2026, subject to the Reporting Person's continuous service with the Issuer as of each such date. Read SEC document |
| January 16, 2026 Filed Jan 21, 2026 21:36 UTC |
Shefferman JesseDirector · CEO and President
|
GrantStock Option (Right to Buy) · Derivative | 524,000 | $0.00 Strike: $5.01 | $0.00 |
DisclosureSEC source: 0001213900-26-006226 · marketforms-71894.xml · derivative · entry 2 Shefferman Jesse · CIK 0001799167 · Director · CEO and President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 524,000 Underlying: Common Stock · 524,000 shares Expires 2036-01-15 F2 · derivative.exercise_date: 25% of the shares vest on the one year anniversary of January 16, 2026 and 1/48th of the shares vest monthly thereafter over the next three years, subject to the Reporting Person's continuous service with the Issuer as of each such date. Read SEC document |
| January 16, 2026 Filed Jan 21, 2026 21:36 UTC |
Shefferman JesseDirector · CEO and President
|
GrantCommon Stock | 87,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001213900-26-006226 · marketforms-71894.xml · nonDerivative · entry 1 Shefferman Jesse · CIK 0001799167 · Director · CEO and President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,046,886 F1 · shares: The shares being reported are being issued pursuant to restricted stock unit awards (RSUs), each of which represents a contingent right to receive one share of Issuer's common stock. The RSUs vest in equal one third installments on the first, second and third anniversaries of January 16, 2026, subject to the Reporting Person's continuous service with the Issuer as of each such date. Read SEC document |
| June 27, 2025 Filed Jun 30, 2025 20:10 UTC |
Shefferman JesseDirector · CEO and President
|
GiftCommon Stock | 3,367 | $0.00 | $0.00 |
DisclosureSEC source: 0001213900-25-059655 · marketforms-69999.xml · nonDerivative · entry 4 Shefferman Jesse · CIK 0001799167 · Director · CEO and President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 959,886 Read SEC document |
| June 27, 2025 Filed Jun 30, 2025 20:10 UTC |
Shefferman JesseDirector · CEO and President
|
GiftCommon Stock | 10,200 | $0.00 | $0.00 |
DisclosureSEC source: 0001213900-25-059655 · marketforms-69999.xml · nonDerivative · entry 3 Shefferman Jesse · CIK 0001799167 · Director · CEO and President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 963,253 Read SEC document |
| June 26, 2025 Filed Jun 30, 2025 20:10 UTC |
Shefferman JesseDirector · CEO and President
|
GiftCommon Stock | 3,400 | $0.00 | $0.00 |
DisclosureSEC source: 0001213900-25-059655 · marketforms-69999.xml · nonDerivative · entry 2 Shefferman Jesse · CIK 0001799167 · Director · CEO and President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 973,453 Read SEC document |
| June 26, 2025 Filed Jun 30, 2025 20:10 UTC |
Shefferman JesseDirector · CEO and President
|
GiftCommon Stock | 1,700 | $0.00 | $0.00 |
DisclosureSEC source: 0001213900-25-059655 · marketforms-69999.xml · nonDerivative · entry 1 Shefferman Jesse · CIK 0001799167 · Director · CEO and President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 976,853 Read SEC document |
| June 24, 2025 Filed Jul 7, 2025 20:10 UTC |
Shefferman JesseDirector · CEO and President
|
GiftCommon Stock | 300,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001213900-25-061772 · marketforms-70060.xml · nonDerivative · entry 1 Shefferman Jesse · CIK 0001799167 · Director · CEO and President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 659,886 F1 · ownership.direct: On June 24, 2025, the reporting person transferred 300,000 shares of common stock to The Samhold Family Trust for no consideration. Members of the reporting person's immediate family are the sole beneficiaries of the trust and a member of the reporting person's immediate family serves as a trustee thereof. The reporting person remains the beneficial owner of the securities held by the trust. Read SEC document |
| June 12, 2025 Filed Jun 13, 2025 20:05 UTC |
Solomon Michael EdwardDirector
|
GrantStock Option (Right to Buy) · Derivative | 24,000 | $0.00 Strike: $3.26 | $0.00 |
DisclosureSEC source: 0001213900-25-054288 · marketforms-69818.xml · derivative · entry 1 Solomon Michael Edward · CIK 0001799320 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 24,000 Underlying: Common Stock · 24,000 shares Expires 2035-06-11 F1 · derivative.exercise_date: The shares subject to the Annual Grant will vest in full upon the first anniversary of the date of grant, subject to the Eligible Director's continuous service as a member of the Board through such vesting date and will vest in full upon a Change of Control. Read SEC document |
| June 12, 2025 Filed Jun 13, 2025 20:05 UTC |
Huang JaneDirector
|
GrantStock Option (Right to Buy) · Derivative | 24,000 | $0.00 Strike: $3.26 | $0.00 |
DisclosureSEC source: 0001213900-25-054284 · marketforms-69814.xml · derivative · entry 1 Huang Jane · CIK 0001683913 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 24,000 Underlying: Common Stock · 24,000 shares Expires 2035-06-11 F1 · derivative.exercise_date: The shares subject to the Annual Grant will vest in full upon the first anniversary of the date of grant, subject to the Eligible Director's continuous service as a member of the Board through such vesting date and will vest in full upon a Change of Control. Read SEC document |
| June 12, 2025 Filed Jun 13, 2025 20:05 UTC |
Levy Richard SDirector
|
GrantStock Option (Right to Buy) · Derivative | 24,000 | $0.00 Strike: $3.26 | $0.00 |
DisclosureSEC source: 0001213900-25-054285 · marketforms-69815.xml · derivative · entry 1 Levy Richard S · CIK 0001454983 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 24,000 Underlying: Common Stock · 24,000 shares Expires 2035-06-11 F1 · derivative.exercise_date: The shares subject to the Annual Grant will vest in full upon the first anniversary of the date of grant, subject to the Eligible Director's continuous service as a member of the Board through such vesting date and will vest in full upon a Change of Control. Read SEC document |
| June 12, 2025 Filed Jun 13, 2025 20:05 UTC |
GARCEAU ROGERDirector
|
GrantStock Option (Right to Buy) · Derivative | 24,000 | $0.00 Strike: $3.26 | $0.00 |
DisclosureSEC source: 0001213900-25-054283 · marketforms-69813.xml · derivative · entry 1 GARCEAU ROGER · CIK 0001451767 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 24,000 Underlying: Common Stock · 24,000 shares Expires 2035-06-11 F1 · derivative.exercise_date: The shares subject to the Annual Grant will vest in full upon the first anniversary of the date of grant, subject to the Eligible Director's continuous service as a member of the Board through such vesting date and will vest in full upon a Change of Control. Read SEC document |
| June 12, 2025 Filed Jun 13, 2025 20:05 UTC |
SARGEN GREGORYDirector
|
GrantStock Option (Right to Buy) · Derivative | 24,000 | $0.00 Strike: $3.26 | $0.00 |
DisclosureSEC source: 0001213900-25-054286 · marketforms-69816.xml · derivative · entry 1 SARGEN GREGORY · CIK 0001227835 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 24,000 Underlying: Common Stock · 24,000 shares Expires 2035-06-11 F1 · derivative.exercise_date: The shares subject to the Annual Grant will vest in full upon the first anniversary of the date of grant, subject to the Eligible Director's continuous service as a member of the Board through such vesting date and will vest in full upon a Change of Control. Read SEC document |
| June 12, 2025 Filed Jun 13, 2025 20:05 UTC |
BESHAR LUKE MDirector
|
GrantStock Option (Right to Buy) · Derivative | 24,000 | $0.00 Strike: $3.26 | $0.00 |
DisclosureSEC source: 0001213900-25-054280 · marketforms-69807.xml · derivative · entry 1 BESHAR LUKE M · CIK 0001192128 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 24,000 Underlying: Common Stock · 24,000 shares Expires 2035-06-11 F1 · derivative.exercise_date: The shares subject to the Annual Grant will vest in full upon the first anniversary of the date of grant, subject to the Eligible Director's continuous service as a member of the Board through such vesting date and will vest in full upon a Change of Control. Read SEC document |
| June 12, 2025 Filed Jun 13, 2025 20:05 UTC |
Smith CynthiaDirector
|
GrantStock Option (Right to Buy) · Derivative | 24,000 | $0.00 Strike: $3.26 | $0.00 |
DisclosureSEC source: 0001213900-25-054287 · marketforms-69817.xml · derivative · entry 1 Smith Cynthia · CIK 0001609480 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 24,000 Underlying: Common Stock · 24,000 shares Expires 2035-06-11 F1 · derivative.exercise_date: The shares subject to the Annual Grant will vest in full upon the first anniversary of the date of grant, subject to the Eligible Director's continuous service as a member of the Board through such vesting date and will vest in full upon a Change of Control. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.